We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

63 hedge funds and large institutions have $42.1M invested in BioDelivery Sciences International, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

3% more capital invested

Capital invested by funds: $40.8M → $42.1M (+$1.29M)

18% less funds holding

Funds holding: 77 → 63 (-14)

22% less call options, than puts

Call options by funds: $134K | Put options by funds: $172K

45% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 20

Holders
63
Holders Change
-14
Holders Change %
-18.18%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
20
Reduced
17
Closed
20
Calls
$134K
Puts
$172K
Net Calls
-$38K
Net Calls Change
-$173K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.35M
2
GCP
GSA Capital Partners
United Kingdom
+$700K
3
HP
Hikari Power
Japan
+$510K
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$482K
5
SCM
Stonepine Capital Management
Oregon
+$471K

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$1.48M
2
ACA
Avoro Capital Advisors
New York
-$1.13M
3
RA
Royce & Associates
New York
-$965K
4
EC
Engaged Capital
California
-$330K
5
Morgan Stanley
Morgan Stanley
New York
-$330K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
51
IFP Advisors
Florida
$8K +$1.1K +571 +16%
LTFS
52
Ladenburg Thalmann Financial Services
Florida
$6K -$1.93K -1,000 -23%
Creative Planning
53
Creative Planning
Kansas
$4K +$1.93K +1,000 +77%
Bank of America
54
Bank of America
North Carolina
$3K – – –
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
Citigroup
56
Citigroup
New York
$2K – – –
AA
57
AlphaMark Advisors
Kentucky
$2K +$964 +500 +83%
CG
58
Cutler Group
California
$1K – – –
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$1K +$27 +14 +4%
MTIP
60
Magee Thomson Investment Partners
California
$1K +$577 +299 New
Walleye Trading
61
Walleye Trading
New York
$2 +$1.93K +1,000 New
ACA
62
Avoro Capital Advisors
New York
– -$1.13M -644,176 Closed
RA
63
Royce & Associates
New York
– -$965K -551,200 Closed
EC
64
Engaged Capital
California
– -$330K -188,750 Closed
OAM
65
Oxford Asset Management
United Kingdom
– -$189K -107,945 Closed
TCIM
66
TIAA CREF Investment Management
New York
– -$142K -81,150 Closed
CS
67
Credit Suisse
Switzerland
– -$129K -73,233 Closed
Citadel Advisors
68
Citadel Advisors
Florida
– -$132K -68,585 Closed
TAM
69
Tiverton Asset Management
Delaware
– -$83K -47,517 Closed
EP
70
Elkfork Partners
Oregon
– -$52K -29,954 Closed
TSS
71
Two Sigma Securities
New York
– -$49K -27,884 Closed
TC
72
TFS Capital
Pennsylvania
– -$45K -25,517 Closed
GHCM
73
Glen Harbor Capital Management
California
– -$43K -24,668 Closed
MCIM
74
Meadow Creek Investment Management
Georgia
– -$34K -19,382 Closed
Wolverine Trading
75
Wolverine Trading
Illinois
– -$29K -16,730 Closed
1 2
3
4

BDSI Hedge Fund Activity: Q1 2017 in Review

63 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2017, worth a combined $42.1M — up 3.2% from $40.8M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of BDSI and 11 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 20 added.

The largest buyer was BlackRock, opening a new position worth an estimated $2.35M. The largest seller was Ameriprise, cutting an estimated $1.48M.

  • 63 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2017, down from 77 in Q4 2016.
  • Funds reported $42.1M of BioDelivery Sciences International, Inc. stock for Q1 2017, up 3.2% quarter-over-quarter.
  • 11 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2017 and 20 closed out, a net change of -9 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q1 2017 was BlackRock, an estimated $2.35M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q1 2017 was Ameriprise, an estimated $1.48M sold.

Based on aggregated 13F filings for Q1 2017.